Apr 15 |
First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference
|
Mar 18 |
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
|
Mar 14 |
First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease
|
Mar 14 |
First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
|
Mar 5 |
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
|
Mar 4 |
First Wave Biopharma to raise about $4M of proceeds in direct offering
|
Mar 4 |
First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
|
Feb 13 |
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
|
Jan 23 |
First Wave BioPharma to Present at the DealFlow MicroCap Conference
|
Jan 17 |
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
|